Abstract
We report three pediatric patients with ganciclovir-resistant cytomegalovirus (CMV) retinitis who were successfully treated with foscarnet. The patients were recipients of hematopoietic stem cell transplantation (SCT) from HLA-mismatched donors. Because these patients had developed or experienced progressive CMV retinitis during ganciclovir therapy, they received foscarnet therapy at 60 mg/kg every 8 h. Their retinitis resolved promptly after initiating foscarnet therapy, suggesting foscarnet's effectiveness in treating ganciclovir-resistant CMV infection. The amount of CMV mRNA was quantitatively measured using an NASBA technique, which amplified the β2.7 transcripts specific for CMV replication. This technique was useful for monitoring disease activity in a more rapid and sensitive manner than the PCR assay for CMV DNA. Bone Marrow Transplantation (2001) 27, 1141–1145.
Similar content being viewed by others
References
Erice A, Chou S, Biron KK et al. Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients New Engl J Med 1989 320: 289–293
Jacobson MA, Drew WL, Feinberg J et al. Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS J Infect Dis 1991 163: 1348–1351
Drobyski WR, Knox KK, Carrigan DR, Ash RC . Foscarnet therapy of ganciclovir-resistant cytomegalovirus in marrow transplantation Transplantation 1991 52: 155–157
Dieterich DT, Poles MA, Dicker M et al. Foscarnet treatment of cytomegalovirus gastrointestinal infections in acquired immunodeficiency syndrome patients who have failed ganciclovir induction Am J Gastroenterol 1993 88: 542–548
Balfour HH Jr . Antiviral drugs New Engl J Med 1999 340: 1255–1268
Drew WL . Clinical use of ganciclovir for cytomegalovirus infection and the development of drug resistance J Acquir Immune Defic Syndr 1991 4: (Suppl. 1) S42–46
Kievits T, van Gemen B, van Strijp D et al. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection J Virol Meth 1991 35: 273–286
Aono T, Kondo K, Miyoshi H et al. Monitoring of human cytomegalovirus infections in pediatric bone marrow transplant recipients by nucleic acid sequence-based amplification J Infect Dis 1998 178: 1244–1249
Gerna G, Baldanti F, Lilleri D et al. Human cytomegalovirus immediate–early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients J Clin Microbiol 2000 38: 1845–1853
Kondo K, Xu J, Mocarski ES . Human cytomegalovirus latent gene expression in granulocyte–macrophage progenitors in culture and in seropositive individuals Proc Natl Acad Sci USA 1996 93: 11137–11142
Miyoshi H, Tanaka-Taya K, Nagae Y et al. Cytomegalovirus retinitis after transplantation of positively selected CD34+ cells from HLA-mismatched donors Pediatr Infect Dis J 1998 17: 345–348
Chou S, Marousek G, Guentzel S et al. Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease J Infect Dis 1997 176: 786–789
Pérez JL . Resistance to antivirals in human cytomegalovirus: mechanisms and clinical significance Microbiologia 1997 13: 343–352
Jacobson MA, Kramer F, Bassiakos Y et al. Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS clinical Trials Group Protocol 151 J Infect Dis 1994 170: 189–193
Walton RC, Whitcup SM, Mueller BU et al. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis Ophthalmology 1995 102: 1865–1870
Bacigalupo A, Bregante S, Tedone E et al. Combined foscarnet-ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation Transplantation 1996 62: 376–380
Manfredi R, Mastroianni A, Coronado OV, Chiodo F . The treatment of AIDS-related cytomegalovirus disease with ganciclovir and foscarnet association. Three case reports Recent Prog Med 1996 87: 545–548
Gondo H, Minematsu T, Harada M et al. Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation Br J Haematol 1994 86: 130–137
Hebart H, Müller C, Löffler J et al. Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation Bone Marrow Transplant 1996 17: 861–868
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ohta, H., Matsuda, Y., Tokimasa, S. et al. Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis after stem cell transplantation: effective monitoring of CMV infection by quantitative analysis of CMV mRNA. Bone Marrow Transplant 27, 1141–1145 (2001). https://doi.org/10.1038/sj.bmt.1703055
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703055
- Springer Nature Limited